Many were also overexpressed in CAFs from the mouse PyMT mammary and KRas/p53 pancreatic cancer models (Calvo et al. 2013; Ohlund et al. 2017) and from human pancreatic, oral, and breast carcinoma (Table 1F,G; Supplemental Tables S4–S7; Farmer et al. 2009; Lim et al. 2011; Moffitt et al. 2015; Ohlund et al. 2017). This evidence concerns the gene KRAS and breast carcinoma.